GHK-Cu is present in plasma, saliva, and urine, with plasma levels declining with age
The total peptide content is listed on the product label
These safety characterisation studies have established the pre-clinical basis for the well-tolerated profile of both peptides in rodent research models and havent identified significant toxicological findings at doses producing meaningful biological effects and contributing to their establishment as reference research compounds in pre-clinical regenerative biology
Compounded wellness formulations are prepared by state-licensed U.S
AHK-Cu (Alanyl-Histidyl-Lysine:Copper(II))# AHK-Cu is the closest structural analog to GHK-Cu, differing only in the substitution of glycine (position 1) with alanine
PrymaLab BPC-157 is supplied at 5mg/ml in a sealed, preloaded 3ml autoinjector pen, with an optional glass reloading cylinder for standardized refills between research runs